A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Fonterra on India: no dairy, no deal
Primary Sector

Fonterra on India: no dairy, no deal

Co-op says it "wouldn't be acceptable" to sign an India trade deal excluding dairy.

Analysts upbeat about Scales lifting its apple game
Primary Sector

Analysts upbeat about Scales lifting its apple game

The deal with Bostock Group promises to deliver more premium fruit for Mr Apple.

Fonterra's white flag over white gold
Primary Sector

Dileepa Fonseka: Fonterra's white flag over white gold

Fonterra waves the white flag in the national quest for 'value add'.

Jarden: $2 per share capital return possible if Fonterra gets full price for consumer business
Primary Sector

Jarden: $2 per share capital return possible if Fonterra gets full price for consumer business

Analyst believes a sale worth $3.4b all up is in the 'realms of possibility'.

Riley Kennedy 17 May 2024